Market Cap 418.34M
Revenue (ttm) 0.00
Net Income (ttm) -294.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 387,300
Avg Vol 626,746
Day's Range N/A - N/A
Shares Out 104.06M
Stochastic %K 49%
Beta -1.47
Analysts Strong Sell
Price Target $19.00

Company Profile

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company's clinical asset comprises ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. It also develops interferon regulatory factor 5 (IRF5) to ad...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 231 6625
Address:
280 East Grand Avenue, South San Francisco, United States
BIOTECH_GURU
BIOTECH_GURU Oct. 4 at 11:45 PM
$ALMS reviewed their data. Very high likelihood of success. I will buy a shit ton if it dips. I expect this to be trading in the 20s once trial data is announced. ****nfa**** Good luck all.
0 · Reply
highnihilism
highnihilism Sep. 30 at 12:54 PM
$TALO Talos Energy: 48 trades, $13.5K vs $14K avg (0.95x). $12.8K calls / $0.7K puts. $XRAY Dentsply Sirona: 50 trades, $15.6K vs $36K avg (0.44x). $12.7K calls / $2.9K puts. $FOLD Amicus Therapeutics: 28 trades, $25.7K vs $37K avg (0.69x). $12.7K calls / $13K puts. $ALMS Alumis: 26 trades, $14.5K vs $17K avg (0.86x). $12.7K calls / $1.8K puts.
0 · Reply
TalkMarkets
TalkMarkets Sep. 29 at 10:05 PM
Bargain Hunters’ Delight: Four Stocks Trading Below Cash Per Share With Minimal Debt $GDOT $ARVN $KROS $ALMS https://talkmarkets.com/content/stocks--equities/bargain-hunters-delight-four-stocks-trading-below-cash-per-share-with-minimal-debt?post=525519
0 · Reply
Jhgfyij
Jhgfyij Sep. 29 at 9:11 PM
0 · Reply
24oldmillclear
24oldmillclear Sep. 29 at 1:55 AM
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Sep. 29 at 12:21 AM
$ALMS insiders buying. 🔥🔥🔥🚀🚀🚀
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Sep. 24 at 5:03 PM
Liked the move $NKTR and $QURE made. $ALMS I really like! Low float, microcap with a high ocane pipeline that can move the needle in a hurry. Due for psoriasis readout in q1 2026. If early data is positive it can be announced a few months sooner which will cause a monster move. Don't say I didn't tell ya! ***Not financial advice***
0 · Reply
highnihilism
highnihilism Sep. 22 at 12:50 PM
IWM: Russell 2000 → $NEXN Nexxen International $DGICA Donegal Group $ALEX Alexander & Baldwin Common REIT $HLX Helix Energy $ALMS Alumis
0 · Reply
10xby3
10xby3 Sep. 19 at 2:13 AM
$ALMS $ 5er then $6 lets go!
0 · Reply
highnihilism
highnihilism Sep. 17 at 9:44 AM
IWM: Russell 2000 → $NEXN Nexxen International $DGICA Donegal Group $ALEX Alexander & Baldwin Common REIT $HLX Helix Energy $ALMS Alumis
0 · Reply
Latest News on ALMS
Alumis Completes Merger with ACELYRIN

May 21, 2025, 9:10 AM EDT - 4 months ago

Alumis Completes Merger with ACELYRIN


Alumis Stockholders Approve Merger with ACELYRIN

May 13, 2025, 1:00 PM EDT - 5 months ago

Alumis Stockholders Approve Merger with ACELYRIN


Alumis and ACELYRIN Announce Amended Merger Agreement

Apr 21, 2025, 6:30 AM EDT - 5 months ago

Alumis and ACELYRIN Announce Amended Merger Agreement


Top 3 Health Care Stocks That May Crash In Q2

Apr 7, 2025, 11:23 AM EDT - 6 months ago

Top 3 Health Care Stocks That May Crash In Q2

CMRX DERM


Alumis to Present at Leerink's 2025 Global Healthcare Conference

Mar 10, 2025, 8:00 AM EDT - 7 months ago

Alumis to Present at Leerink's 2025 Global Healthcare Conference


Alumis Strengthens Leadership Team with Key Appointments

Jan 28, 2025, 8:00 AM EST - 8 months ago

Alumis Strengthens Leadership Team with Key Appointments


Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut

Jun 28, 2024, 12:58 PM EDT - 1 year ago

Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut


Alumis Announces Pricing of Initial Public Offering

Jun 27, 2024, 11:57 PM EDT - 1 year ago

Alumis Announces Pricing of Initial Public Offering


Alumis eyes $300 million in proceeds in IPO

Jun 24, 2024, 7:18 AM EDT - 1 year ago

Alumis eyes $300 million in proceeds in IPO


Alumis' $100 Million IPO: Promising Psoriasis Treatment Results

Jun 11, 2024, 12:25 PM EDT - 1 year ago

Alumis' $100 Million IPO: Promising Psoriasis Treatment Results


BIOTECH_GURU
BIOTECH_GURU Oct. 4 at 11:45 PM
$ALMS reviewed their data. Very high likelihood of success. I will buy a shit ton if it dips. I expect this to be trading in the 20s once trial data is announced. ****nfa**** Good luck all.
0 · Reply
highnihilism
highnihilism Sep. 30 at 12:54 PM
$TALO Talos Energy: 48 trades, $13.5K vs $14K avg (0.95x). $12.8K calls / $0.7K puts. $XRAY Dentsply Sirona: 50 trades, $15.6K vs $36K avg (0.44x). $12.7K calls / $2.9K puts. $FOLD Amicus Therapeutics: 28 trades, $25.7K vs $37K avg (0.69x). $12.7K calls / $13K puts. $ALMS Alumis: 26 trades, $14.5K vs $17K avg (0.86x). $12.7K calls / $1.8K puts.
0 · Reply
TalkMarkets
TalkMarkets Sep. 29 at 10:05 PM
Bargain Hunters’ Delight: Four Stocks Trading Below Cash Per Share With Minimal Debt $GDOT $ARVN $KROS $ALMS https://talkmarkets.com/content/stocks--equities/bargain-hunters-delight-four-stocks-trading-below-cash-per-share-with-minimal-debt?post=525519
0 · Reply
Jhgfyij
Jhgfyij Sep. 29 at 9:11 PM
0 · Reply
24oldmillclear
24oldmillclear Sep. 29 at 1:55 AM
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Sep. 29 at 12:21 AM
$ALMS insiders buying. 🔥🔥🔥🚀🚀🚀
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Sep. 24 at 5:03 PM
Liked the move $NKTR and $QURE made. $ALMS I really like! Low float, microcap with a high ocane pipeline that can move the needle in a hurry. Due for psoriasis readout in q1 2026. If early data is positive it can be announced a few months sooner which will cause a monster move. Don't say I didn't tell ya! ***Not financial advice***
0 · Reply
highnihilism
highnihilism Sep. 22 at 12:50 PM
IWM: Russell 2000 → $NEXN Nexxen International $DGICA Donegal Group $ALEX Alexander & Baldwin Common REIT $HLX Helix Energy $ALMS Alumis
0 · Reply
10xby3
10xby3 Sep. 19 at 2:13 AM
$ALMS $ 5er then $6 lets go!
0 · Reply
highnihilism
highnihilism Sep. 17 at 9:44 AM
IWM: Russell 2000 → $NEXN Nexxen International $DGICA Donegal Group $ALEX Alexander & Baldwin Common REIT $HLX Helix Energy $ALMS Alumis
0 · Reply
777Dog
777Dog Sep. 9 at 2:26 PM
$ALMS picked up a few more at 4.14…good luck everybody…
2 · Reply
777Dog
777Dog Sep. 9 at 2:18 PM
$ALMS below cash, first and best in $100+ billion market…let’s see how far down the tutes take it while they accumulate No bad news, steady progress…still buying as we wait…
0 · Reply
JarvisFlow
JarvisFlow Sep. 9 at 10:00 AM
Oppenheimer has adjusted their stance on Alumis ( $ALMS ), setting the rating to Outperform with a target price of 32 → 26.
0 · Reply
777Dog
777Dog Sep. 4 at 2:47 AM
$ALMS listened to presentation. Honestly could not hear much due to audio troubles. They have several very positive studies awaiting completion. Confirmed that phase3 going as predicted by phase 2. They are awaiting results to decide on best allocation of $$$ Several hints at partner likely for launches. CEO is all business and very smart. $20 target is real…will continue to buy dips as it climbs with tutes accumulating.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 3 at 11:42 AM
$ALMS Great piece that accurately captures ALMS's current position. So if you want to refresh your understanding of ALMS or learn about ALMS for the first time, this is essential reading. https://beyondspx.com/quote/ALMS/alumis-a-transformed-pipeline-and-strengthened-balance-sheet-post-merger-alms#analysis
0 · Reply
777Dog
777Dog Sep. 3 at 2:47 AM
$ALMS Updates please...$20 Cantor Global Healthcare Conference 2025 in New York, NY on September 3 at 9:45 am ET (fireside chat); Wells Fargo 2025 Healthcare Conference in Boston, MA on September 5 at 9:30 am ET (fireside chat); Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY on September 8 at 4:50 pm ET (fireside chat); H.C. Wainwright 27th Annual Global Investment Conference in New York, NY on September 9 at 10:30 am ET (presentation); Baird 2025 Global Healthcare Conference in New York, NY on September 10 at 2:35 pm ET (presentation); and Stifel 2025 Virtual Immunology & Inflammation Forum on September 16 at 12:30 pm ET (virtual presentation)
0 · Reply
DCRMIA
DCRMIA Aug. 31 at 9:06 PM
$ALMS Super bullish🚀🚀🚀🚀
0 · Reply
777Dog
777Dog Aug. 27 at 1:59 PM
$ALMS For any possible newbies...the chart is painted...tutes loading...
0 · Reply
777Dog
777Dog Aug. 27 at 1:48 PM
$ALMS Great stock to watch...tutes loading while we wait...no reason to think phase 3 will fail, and company run by competent CEO who knows how to get acquired by big Pharma. Flush with cash... Will continue to buy the dips and enjoy the ride to 20 bucks...target is real... good luck everybody...sleeper...
0 · Reply
MarketPro
MarketPro Aug. 24 at 10:53 PM
$ALMS Top Institutional Holders by Market Value. Arrows to the right: Increase / Decrease ..... Looks all green to me....
0 · Reply
SignalPathfinder
SignalPathfinder Aug. 23 at 5:21 AM
$ALMS Almado is a small cap company with limited financial disclosure and trading history posing investment risks
1 · Reply
Sportsfanbar510
Sportsfanbar510 Aug. 22 at 10:24 PM
$ALMS is this also slrn stock?
0 · Reply